22 unchanged sentences
Not applicable.
−Removed: 2024 Annual Report
Directors, executive officers and corporate governance
20 unchanged sentences
and Note 16 Common stock, stock option plans and stock compensation agreements of the Notes to Consolidated Financial Statements in Item 8 of this Report.
+Added: 2025 Annual Report
Equity compensation plan information
24 unchanged sentences
Ratification of appointment of independent registered public accounting firm in the Proxy Statement.
−Removed: 2024 Annual Report
Exhibits and financial statement schedules
8 unchanged sentences
Report of independent registered public accounting firm
−Removed: All schedules are omitted because they are not applicable or the required information is included in the financial statements or notes.
+Added: All schedules are omitted because they are not applicable, not material or the required information is included in the financial statements or notes.
Exhibits required to be filed by item 60l of regulation S-K
3 unchanged sentences
The Company has elected not to include such summary information.
+Added: 2025 Annual Report
Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
15 unchanged sentences
Director February 11, 2026
−Removed: 2024 Annual Report
Signature Title Date
7 unchanged sentences
Director February 11, 2026
+Added: 2025 Annual Report
Exhibit index
20 unchanged sentences
Amended and Restated Deferred Fee Plan for Directors (Amended as of January 17, 2012) — Incorporated herein by reference to Exhibit 10(k) of the Registrant's Form 10-K Annual Report for the fiscal year ended January 1, 2012.*
−Removed: 2024 Annual Report
Exhibit Table
21 unchanged sentences
Amendment One to the Johnson & Johnson Excess Savings Plan (amended and restated effective as of January 1, 2022) — Incorporated herein by reference to Exhibit 10.1 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended October 1, 2023.*
+Added: 2025 Annual Report
Exhibit Table
Johnson & Johnson Executive Incentive Plan (Amended as of September 7, 2023) — Incorporated herein by reference to Exhibit 10.2 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended October 1, 2023.*
−Removed: Johnson & Johnson Executive Officer Cash Severance Policy — Filed with this document.*
+Added: Johnson & Johnson Executive Officer Cash Severance Policy — Incorporated herein by reference to Exhibit 10(ab) of the Registrant's Form 10-K Annual Report for the fiscal year ended December 29, 2024.*
Johnson & Johnson Stock Trading Policy for Directors, Executive Officers and Insiders (Amended as of April 27, 2023) — Incorporated herein by reference to Exhibit 19 of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 31, 2023.
20 unchanged sentences
The Company hereby agrees to furnish a copy of any such instrument to the SEC upon request.
−Removed: 2024 Annual Report
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.